American Journal of Gastroenterology

American Journal of Gastroenterology is the peer-reviewed official journal of the American College of Gastroenterology published by Wolters Kluwer under the Lippincott Williams and Wilkins imprint since 1909 under the ISSN 0002-9270 and eISSN 1572-0241, covering clinical gastroenterology and hepatology, with a 2025 Journal Impact Factor of 8.5 and a first quartile rank of 15 of 153 in gastroenterology and hepatology《美国胃肠病学杂志》（American Journal of Gastroenterology）是美国胃肠病学会（ACG）的官方同行评审期刊，由沃尔特斯克鲁沃（Wolters Kluwer）以利平科特威廉威尔金斯（Lippincott Williams and Wilkins）印记自 1909 年起出版，刊号 0002-9270、电子刊号 1572-0241，覆盖临床胃肠病与肝病学，2025 年影响因子为 8.5，在胃肠与肝病学类 153 种期刊中列第 15 位、居第一四分位。

Scope

• The journal is the official publication of the American College of Gastroenterology and publishes original research, reviews, guidelines, editorials and case reports across the breadth of clinical gastroenterology and hepatology该刊是美国胃肠病学会（ACG）的官方出版物，刊载临床胃肠病与肝病学各领域的原创研究、综述、指南、社论与病例报告。
• It covers inflammatory bowel disease including Crohn disease and ulcerative colitis, irritable bowel syndrome, gastroesophageal reflux disease, peptic ulcer disease, functional gastrointestinal disorders and colorectal cancer screening and prevention该刊覆盖炎症性肠病（含克罗恩病与溃疡性结肠炎）、肠易激综合征、胃食管反流病、消化性溃疡病、功能性胃肠病及结直肠癌筛查与预防。
• The journal addresses hepatology including viral hepatitis, non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease, cirrhosis and its complications, hepatocellular carcinoma and liver transplantation该刊涉及肝病学，包括病毒性肝炎、非酒精性脂肪肝与代谢功能障碍相关脂肪性肝病、肝硬化及其并发症、肝细胞癌与肝移植。
• It also covers endoscopy including advanced endoscopic techniques, endoscopic ultrasound, capsule endoscopy, the management of gastrointestinal bleeding and biliary and pancreatic disorders, and nutrition in gastrointestinal disease该刊亦覆盖内镜学，包括高级内镜技术、超声内镜、胶囊内镜、胃肠出血与胆胰疾病的管理，以及胃肠疾病的营养支持。
• It operates single-blind peer review and follows the Wolters Kluwer editorial policies on research integrity, data availability and competing interests, with author guidelines published on the journal website该刊实行单盲同行评审，遵循沃尔特斯克鲁沃关于研究诚信、数据可获取性与利益冲突的编辑政策，作者指南在期刊网站公布。
• In the 2025 Journal Citation Reports it ranks 15 of 153 titles in gastroenterology and hepatology with a 90.5 percentile and its five year indicator remains in the first quartile在 2025 年版期刊引证报告中，该刊在胃肠与肝病学类 153 种期刊中列第 15 位、百分位 90.5，五年指标同样位于第一四分位。

History

• The journal was launched in 1909 as the official organ of the American College of Gastroenterology, and it has served as the society's flagship clinical journal throughout its history, publishing the ACG clinical guidelines and practice updates该刊于 1909 年作为美国胃肠病学会（ACG）的机关刊物创刊，历史上一直是该学会的旗舰临床期刊，刊载（ACG）临床指南与实践更新。
• It has been published monthly throughout most of its history, with twelve issues per volume per year, and it moved to the Wolters Kluwer Lippincott Williams and Wilkins imprint as part of the consolidation of medical publishing该刊历史上大部分时间以月刊形式出版，每年一卷十二期，随医学出版整合归入沃尔特斯克鲁沃利平科特威廉威尔金斯印记。
• The Journal Impact Factor moved from 10.864 in 2021 to 12.045 in 2022, then to 7.6 in 2024 and to 8.5 in 2025, maintaining first quartile standing in gastroenterology and hepatology throughout该刊影响因子由 2021 年的 10.864 升至 2022 年的 12.045，再降至 2024 年的 7.6 与 2025 年的 8.5，始终居胃肠与肝病学类第一四分位。
• The journal has served as the venue for the American College of Gastroenterology clinical guidelines on inflammatory bowel disease, colorectal cancer screening, GERD, pancreatic cysts and hepatic disorders, which are widely adopted in clinical practice该刊一直是美国胃肠病学会（ACG）关于炎症性肠病、结直肠癌筛查、胃食管反流病、胰腺囊肿与肝病的临床指南发布平台，这些指南在临床实践中被广泛采用。
• The publisher carries the journal on its medical publishing platform and the digital object identifier prefix of its articles is 10.14309, shared with other American College of Gastroenterology titles出版方将该刊载于其医学出版平台，其文章的数字对象唯一标识符前缀为（10.14309），与美国胃肠病学会（ACG）其他期刊一致。

Editors

• The journal is led by an editor-in-chief supported by an editorial board whose members are drawn from gastroenterology and hepatology departments, academic medical centres and clinical practice across the United States and internationally该刊由一位主编带领，配以由美国及国际多所胃肠与肝病科院系、学术医学中心与临床实践的学者组成的编委会。
• The editorial team includes associate editors responsible for subject areas such as inflammatory bowel disease, hepatology, interventional endoscopy, functional bowel disorders and colorectal cancer screening, reflecting the breadth of clinical gastroenterology编辑团队设有副编辑，分别负责炎症性肠病、肝病学、介入内镜、功能性肠病与结直肠癌筛查等方向，对应临床胃肠病学的广度。
• Editorial handling follows the Wolters Kluwer editorial management system, with submissions assigned to handling editors based on subject expertise and competing interest declarations稿件处理依托沃尔特斯克鲁沃的编辑管理系统，依据学科专长与利益冲突声明分配责任编辑。
• Peer review is single-blind and the journal maintains the American College of Gastroenterology and Wolters Kluwer standards on reviewer recruitment, conflict of interest management, data sharing and editorial independence同行评审采用单盲方式，该刊遵循美国胃肠病学会（ACG）与沃尔特斯克鲁沃在审稿人遴选、利益冲突管理、数据共享与编辑独立性方面的标准。
• The masthead and board roster are published on the journal page and updated as new members join or existing members step down编委名单在期刊页公布，并随成员增减而更新。